AVIR SCHEDULE 13G: SEC filing
Tang Capital Partners and affiliated entities
Filed with the SEC on · accession 0001214659-26-012604
AVIR filed a SCHEDULE 13G (schedule 13g) with the SEC on Oct 6, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -1.2% by the first close after the filing.
Summary of the filing
Tang Capital Partners and affiliated entities filed a Schedule 13G joint filing agreement regarding their passive ownership stake in Atea Pharmaceuticals common stock.
Key details
How AVIR stock reacted
Close before
$5.13
Oct 5, 2026
First close after
-1.17%
$5.07
5 trading days
-1.95%
$5.03
Since filing
-17.74%
$4.22
✦ Ask GOAX AI about this filing — what it means for AVIR, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for AVIR?
Click hereFrequently asked questions
What did AVIR file with the SEC on Oct 6, 2026?
AVIR filed a SCHEDULE 13G (SEC filing). Tang Capital Partners and affiliated entities filed a Schedule 13G joint filing agreement regarding their passive ownership stake in Atea Pharmaceuticals common stock.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did AVIR stock react to this filing?
AVIR closed at $5.13 before the filing and $5.07 on Oct 6, 2026 (-1.17%). Five trading days later: $5.03 (-1.95%).
Other AVIR SEC filings
Get alerts when AVIR files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days